The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Allergan plc

NYSE: AGN
Last

(U.S.) $303.74

Today's change0.00 0.00%
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $303.74

Today's change0.00 0.00%
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.

Allergan plc closed at (U.S.)$303.74.

Over the last five days, shares have gained 4.08% and 18.00% year to date. Shares have outperformed the S&P 500 by 35.37% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $303.74
  • High--
  • Low--
  • Bid / Ask(U.S.) $253.12 / (U.S.) $309.00
  • YTD % change+18.00%
  • Volume0
  • Average volume (10-day)2,927,611
  • Average volume (1-month)2,615,338
  • Average volume (3-month)2,259,870
  • 52-week range(U.S.) $208.64 to (U.S.) $340.34
  • Beta0.45
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.01×
  • Forward PEG1.06×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$9.35
Updated August 31 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.04%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue5,7554,2344,0573,683
Total other revenue--------
Total revenue5,7554,2344,0573,683
Gross profit3,6252,5212,2261,800
Total cost of revenue2,1301,7131,8311,883
Total operating expense5,9704,5564,6824,705
Selling / general / administrative1,4611,4291,1981,275
Research & development653431468697
Depreciation / amortization1,674925877874
Interest expense (income), net operating--------
Unusual expense (income)5358308-23
Other operating expenses, total--------
Operating income-215-322-625-1,022
Interest income (expense), net non-operating-340-172-128-132
Gain (loss) on sale of assets--------
Other--------
Income before tax-549-690-795-1,151
Income after tax-242-512-733-1,043
Income tax, total-307-178-62-108
Net income-243-512-733-1,043
Total adjustments to net income-70-23----
Net income before extra. items-243-512-733-1,043
Minority interest-2000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-313-535-733-1,043
Inc. avail. to common incl. extra. items-313-535-733-1,043
Diluted net income-313-535-733-1,043
Dilution adjustment--0--0
Diluted weighted average shares393290266264
Diluted EPS excluding extraordinary itemsvalue per share-0.80-1.85-2.76-3.95
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.71-1.72-2.00-4.00